Skip to main content

Home/ MaRS/ Group items tagged Innovative Organizations

Rss Feed Group items tagged

Assunta Krehl

Toronto's $25 million commercialization "engine" celebrates the appointment of its Boar... - 0 views

  • MaRS Innovation is honoured to announce its permanent Board of Directors, who brings together a remarkable and broad set of experiences and networks to support the development of this dynamic partnership of Toronto research institutions.  Designed to enhance the commercial output of Toronto’s world-leading research cluster, MaRS Innovation is positioned to make a significant contribution to Canada’s innovation economy and the quality of life for Canadians and others around the world.
  • upported by the Government of Canada through the Centres of Excellence in Research and Commercialization (CECR) program, and its member institutions, MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. The newly appointed Board of Directors, which includes academic and business leaders from across Canada and the United States, has the targeted expertise to guide MaRS Innovation to deliver on this critical mission.   MaRS Innovation represents a unique collaborative model, which aggregates the exceptional discovery pipeline of 14 leading Toronto academic institutions to build a diversified portfolio of assets, and harness the economic and job creation potential of the best opportunities for Toronto, Ontario and Canada.
  • “MaRS Innovation is privileged to announce a Board of Directors of this caliber and breadth of skill,” said Mary Jo Haddad, Chair of the MaRS Innovation Board and President and CEO of The Hospital for Sick Children. “The collective experience and guidance of these individuals will be critical to developing a collaborative, integrated and agile approach to this transformational organization that will move Canada into its next phase of economic development.”
  • ...2 more annotations...
  • W. Geoffrey Beattie – Deputy Chairman & President, Woodbridge Company Limited, Thomson Reuters Corporation, Toronto Christopher C. Capelli – Vice President, Technology Based Ventures, Office of Technology Commercialization, University of Texas, M.D. Anderson Cancer Center, Houston, TX Ron Close – Information technology entrepreneur, Entrepreneur-in-Residence, MaRS, and Executive Entrepreneur-in-Residence, The Richard Ivey School of Business, The University of Western Ontario, London, ON Nicholas Darby – Formerly Director of Physical Sciences, Corporate Venture Capital, Dow Chemical Company, President, Darby & Associates Consulting LLC, Midland, MI  Mary Jo Haddad – President & CEO, The Hospital for Sick Children, Toronto Jacqueline H.R. Le Saux – Former General Counsel, North America and Corporate Secretary, Patheon, Inc., Toronto David A. Leslie - Chair, Sunnybrook Health Sciences Centre, and Former Chairman & CEO, Ernst & Young, Toronto Michael H. May – President & CEO, Rimon Therapeutics, Toronto Chandra J. Panchal – Founder, President & CEO, Axcelon Biopolymers Corp., Dollard-des-Ormeaux, QC Ilse Treurnicht – CEO, MaRS Discovery District, Toronto Donald A. Wright – President & CEO, The Winnington Capital Group Inc., Toronto
  • MaRS Innovation serves as a business accelerator platform with a single point of entry for industry partners and investors.  It will increase the scale, scope and viability of IP offerings, and the quantity and quality of deal flow from partner institutions.  MaRS Innovation will also facilitate strategic research collaborations with industry partners, strengthen the innovation capacity of Canadian industry through adoption of new technologies from its member institutions, and launch a new generation of robust, high-growth Canadian companies that will become global market leaders.   The quality of the combined discovery pipeline will catalyze and attract sources of risk capital for translational research, market validation, company formation and growth.  “MaRS Innovation represents a unique and timely platform to contribute in a meaningful way to Canada’s knowledge economy, leveraging Toronto’s remarkable research excellence.  The vision and serious commitment of its members to work together to transform our commercialization results, and the support of the Federal Government, made this possible.  The announcement of this outstanding group of leaders to the Board of Directors for MaRS Innovation is an exciting step forward,” said Ilse Treurnicht, MaRS CEO and interim Managing Director of MaRS Innovation.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. Feb 6, 2009
Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

MaRS Innovation appoints president and CEO - University of Toronto -- News@UofT - 0 views

  • MaRS Innovation appoints president and CEO
  • A research commercialization leader from Israel, Dr. Raphael Hofstein, has been named president and CEO of the new MaRS Innovation initiative.
  • MI was created as a single, market-facing commercialization storefront for Toronto's university and health research institutions. Located in the MaRS Discovery District complex, with business development and administrative support from MaRS, MI will advance commercialization through industry partnerships, licensing and company creation. MaRS Innovation (MI) was founded in 2008 with $14.95 million in funding from the Government of Canada's Centres of Excellence for Commercialization and Research (CECR) Programme, matched by $10 million from the research partners. The MI partnership includes U of T, the 10 partner hospitals and health research institutes affiliated with the university, Ryerson University, the Ontario College of Art & Design, BioDisocovery Toronto, the Ontario Institute for Cancer Research and MaRS. Hofstein joins MaRS Innovation from his previous position as president and CEO of Hadasit Ltd., the technology transfer company of the Hadassah Medical Organization in Jerusalem.
  • ...3 more annotations...
  • "MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialization output. In my experience, good science is the single most important ingredient for success in this business. Toronto is already known as one of the strongest science cities in the world, and it continues to grow. Leading MaRS Innovation is a wonderful opportunity to do something remarkable."
  • Dr. Tim McTiernan, assistant vice-president (research) and executive director of The Innovations Group (TIG), U of T's research commercialization operation, said Mars Innovation will provide significant benefits to U of T.
  • And he said that MI's role as a resource "is like putting a turbo charger on an engine. Having MI working with us and the other member organizations is a huge step in taking advantage of the enormous potential in the Toronto research community. Commercialization offices acting independently will not be able to manage in nearly as effective a manner as will be possible with the expertise of MaRS Innovation."
  •  
    Dr. Raphael Hofstein named president and CEO of the new MaRS Innovation initiative.
Sarah Hickman

Podcast: Wharton's Kevin Werbach Speaks with IBM's David Yaun about the Global Innovati... - 0 views

  •  
    Kevin Werbach, a professor of legal studies and business ethics at Wharton, spoke recently with David Yaun, an IBM executive, about the company's Global Innovation Outlook project. According to Yaun, "traditionally, companies have identified innovation with gadgets and gizmos, but that thinking is being transformed." The definition of innovation is being broadened -- it is becoming more open, collaborative, global and inter-disciplinary. "The barriers to innovation and collaboration have come down dramatically," Yaun says. This was the second in a series of interviews about themes to be featured at Supernova, a conference Werbach organizes in collaboration with Wharton in San Francisco.
Sarah Hickman

The Well-Designed Global R&D Network - 0 views

  •  
    Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.
Sarah Hickman

SIX - 0 views

  •  
    The social innovation eXchange (SIX) is a network that has been set up by a group of organizations to help build the emerging field of social innovation. They believe that many of the big problems that the world faces - from climate change to the care needs of an aging population - will only be solved by experiment, enterprise and innovation, and that innovation needs to tap into the creativity of every part of civil society, business and the public sector.
Miri Katz

How The Private Sector Can Drive Social Innovation - CIO Central - CIO Network - Forbes - 0 views

  • How The Private Sector Can Drive Social Innovation
  • Out of the 100 largest economies in the world, about half are multinational corporations. Given their impact on global communities, it is becoming increasingly essential that these large corporations execute responsibility to society, rather than rely on governments and non-profits to address difficult social issues alone.
  • oday, the world’s largest companies are in a unique position to play a much greater role in driving social change than ever before.
  • ...13 more annotations...
  • Aside from pure monetary donations, however, is a new model that is transforming corporate philanthropy.
  • Increasingly, corporations are turning to a shared value model, in which companies work in alignment with society rather than against it, producing mutual benefits to both the community and the corporation
  • It evolves the traditional model of financial and material goods donations, to one in which corporations leverage a range of corporate assets including employee skills, business acumen and partner networks, to drive social change.
  • Here’s the shift: Instead of viewing it as our responsibility to drive business and social value, view it also a valuable opportunity to rethink existing practices.
  • The business case for social innovation
  • there are a variety of benefits for an organization, from brand building, to staff retention, and even improved client stickiness. Shareholders and the investment community are also increasingly considering corporate responsibility when making investment decisions.
  • collaborations can drive innovation through necessity. Non-profits work in extreme environments, faced with limited infrastructure, connectivity and staff. Operating in these situations exposes corporate staff to new sets of customer challenges, which can often deliver innovations in product design or services into the business.
  • by working with a non-profit organization, a corporation can demonstrate its expertise to a new audience, expanding its business network.
  • Increasingly, investors weigh environmental, social and governance  data when making investment decisions. While such data has been a benchmark for European-based companies for some time, we are now seeing a more global adoption and interest in this, which should be another forcing function for more corporations to act as good corporate citizens.
  • Applying social innovation in practic
  • A good starting point is to assess the company’s available skills, expertise, partnerships against the touch-points the company currently has within a given community. From there, establish specific goals to achieve and a strategic plan to meet those goals.
  • Companies that have an expertise in technology, for example, can collaborate with non-profits or social entrepreneurs to provide the infrastructure backbone that turn their ideas into reality. With the social enterprise mPedigree Network, HP leveraged its technology expertise in cloud-based services to design and build an anti-drug counterfeiting service in Africa. Counterfeit medicine is a significant problem in developing countries, causing more than 700,000 deaths each year. The new service helps save lives by enabling patients to validate the integrity of their medicine by sending a free text message.
  • Gabi Zedlmayer is Vice President of Hewlett-Packard’s Office of Global Social Innovation.
  •  
    Out of the 100 largest economies in the world, about half are multinational corporations. Given their impact on global communities, it is increasingly essential that these large corporations execute responsibility to society, rather than rely on governments and non-profits to address difficult social issues alone
Assunta Krehl

Canada's Only Integrated Social Media News Network - Canadian Government Executive Maga... - 0 views

  •  
    Ontario Public Service is interested in looking at the state of innovation in public sector organizations.Some of the leaders who have in public sector innovation are: Social Innovation Generation (SiG), a collaborative partnership between The J.W. McConnell Family Foundation, the University of Waterloo, the MaRS Discovery District, and the PLAN Institute.
Assunta Krehl

Ontario research organizations join forces - ITBusiness.ca - 0 views

  • Three technology research centres in Ontario Monday said they have agreed to work together to help the province compete more effectively against countries like India and China.
  • Communitech is working with the Ottawa Centre for Research and Innovation, an economic development corporation located in the nation's capital, and the MaRS Discovery District, a Toronto-based not-for-profit geared towards the commercialization of scientific and technological intellectual property.
  • MaRS originally stood for Medical and Research Sciences, but has since shied away from that label, said Ross Wallace, director of corporate strategy. The organization doesn't want to be pigeonholed as being just a life sciences or biotechnology outfit -- it lends equal weight to information communications and advanced manufacturing. MaRS may be Toronto-based, but its mandate is province-wide, said Wallace. By joining forces with organizations in other parts of Ontario, MaRS is more likely to fulfill that mandate, he said.
  • ...3 more annotations...
  • The three organizations have agreed their partnership will function under the name the MaRS Network. MaRS is by far the youngest of the three organizations – Communitech is almost a decade old and OCRI is about 25 – but has become a business force since it opened last year.
  • The three organizations aim to share best practices and contacts, and lean on the strengths of their respective regions. All three may have good venture capital resources, for example, but specialties that may be peculiar to a certain area.
  • Dale added that the MaRs Network is open to working with other Canadian technology organizations, including those with a national or a regional focus.
  •  
    Communitech, the Ottawa Centre for Research and Innovation, and the MaRS Discovery District have ageed to work together to help the province compete more effectively against countries like India and China. These three companies partnership will function under the name MaRS Network. May 29, 2005
  •  
    Communitech, the Ottawa Centre for Research and Innovation, and the MaRS Discovery District have ageed to work together to help the province compete more effectively against countries like India and China. These three companies partnership will function under the name MaRS Network.
Assunta Krehl

Inaugural 'Mobile Innovation Week' Announced for Toronto From September 12-16, 2009 - M... - 0 views

  • MobileBiz BootCamp (http://mobilebiz.ca) September 16, 2009 From garage start-up to corporate start-up, at the MobileBiz BootCamp you will earn your stripes by learning from the best in the business. An intensive full day of key insights and fast-track tips delivered by experienced mobile industry leaders, vendors and supporting organizations focused on creating exponential value for all delegates to accelerate profitable growth in their mobile business. Featured speakers from Wind Mobile, Summerhill Capital, Polar Mobile, MaRS, Ontario Centres of Excellence and more. Additional MOBILEINNOVATIONWEEK activities are the ilovemobileweb party - the ultimate mobile industry networking event of the year - and the Mobile ThinkTank where industry experts come together to envision the future of mobile in the global economy. Evening receptions are sponsored by the CWTA, the Mobile Experience Innovation Centre (MEIC) and the Mobile Entertainment Forum (MEF).
  • MOBILEINNOVATIONWEEK from September 12-16, 2009 in Toronto.
  •  
    Mobile Innovation week is from September 12-16 in Toronto where there will be over 100 mobile industry experts will present. MaRS is one organization that will be speaking at Mobilebiz BootCamp on September 16, 2009. This session will focus on how to accelerate profitable growth in a mobile business.
  •  
    Mobile Innovation week is from September 12-16 in Toronto where there will be over 100 mobile industry experts will present. MaRS is one organization that will be speaking at Mobilebiz BootCamp on September 16, 2009. This session will focus on how to accelerate profitable growth in a mobile business. Aug 18, 2009
Assunta Krehl

Farming - solution to economic woes? - Food and Farming Canada - 0 views

  • The recent Agri-Innovation Forum, hosted in Toronto by a few Guelph-based organizations like MaRS Landing and Ontario Agri-Food Technologies who are dedicated to building linkages between agriculture and other sectors such as health, highlighted some of these developments.
  •  
    Blog talks about how Ontario should look at agriculture as a source of solutions and innovation. Mention of Agri-Innovation Forum held by MaRS Landing and Ontario Agri-Food Technologies.
  •  
    Blog talks about how Ontario should look at agriculture as a source of solutions and innovation. Mention of Agri-Innovation Forum held by MaRS Landing and Ontario Agri-Food Technologies. Feb 27, 2009
Cathy Bogaart

The Great Reset - The Atlantic (February 11, 2009) - 0 views

  • What economic crises do is reset the conditions for technological innovation and consumption and demand.
  • If you look at past crises—like the one in the late 19th century and the one that came with the Great Depression—they tended to last about 20 years from beginning to end. But most importantly, these are periods of great technological innovation, and they’re periods in which our economic geography gets completely and massively shifted.
  • we really have to invest in the creativity of each and every individual
  •  
    Richard Florida, urban theorist and lead of the Martin Prosperity Institute housed at MaRS, wrote an article for The Atlantic and this his interview follow-up (web exclusive). He says that it's always been the economic upheavals that have caused the most innovation. Stop artificially supporting dead industries and let the innovative ones organically replace them.
Sarah Hickman

MaRS Discovery District - Recommended Resources - Global Market Reports - VHA Research ... - 0 views

  •  
    "The United States spends more on health care-related research and development than any other country. In 2003, it was estimated that the Federal government alone spent over $26 billion. Pharmaceutical companies, device manufacturers and other private companies invested over $10 billion more. At its best, the American health care system is capable of delivering care unsurpassed anywhere else in the world. Yet, a 1999 Institute of Medicine study estimated that as many as 98,000 Americans die each year from hospital related medical errors. A recent study by the Rand Corporation (a non-profit think tank) concluded that less than 50 percent of encounters with doctors and hospitals resulted in optimal, evidence-based treatment. Studies show that as many as 42 million Americans - almost 15 percent of the population - lack health care insurance. Surveys reveal that patients do not feel they have adequate information about their conditions, and that their experience with health care ranks below that of most other sectors, in fact below that of the post office. In the aggregate, the country is spending nearly $2 trillion on health care, and yet the nation's health care system does not meet acceptable thresholds for safety, quality, access or cost. In 2005, VHA Health Foundation's board of directors sought to better understand the reasons behind this paradox. The foundation commissioned Larry Keeley and his associates at Doblin Inc. to apply the rigorous analytical methods that are used in their evaluation of other American industries and companies. The project set out to discover when, where and how innovation was taking place in health care. It also sought to identify organizations that were developing model innovation processes, and to explore where opportunities for successful innovation might lay."
Assunta Krehl

Inaugural 'Mobile Innovation Week' Announced for Toronto From September 12-16, 2009 - K... - 0 views

  • MOBILEINNOVATIONWEEK from September 12-16, 2009 in Toronto.
  • MobileBiz BootCamp (http://mobilebiz.ca) September 16, 2009 From garage start-up to corporate start-up, at the MobileBiz BootCamp you will earn your stripes by learning from the best in the business. An intensive full day of key insights and fast-track tips delivered by experienced mobile industry leaders, vendors and supporting organizations focused on creating exponential value for all delegates to accelerate profitable growth in their mobile business. Featured speakers from Wind Mobile, Summerhill Capital, Polar Mobile, MaRS, Ontario Centres of Excellence and more.
  •  
    Mobile Innovation week is from September 12-16 in Toronto where there will be over 100 mobile industry experts will present. MaRS is one organization that will be speaking at Mobilebiz BootCamp on September 16, 2009. This session will focus on how to accelerate profitable growth in a mobile business.
  •  
    Mobile Innovation week is from September 12-16 in Toronto where there will be over 100 mobile industry experts will present. MaRS is one organization that will be speaking at Mobilebiz BootCamp on September 16, 2009. This session will focus on how to accelerate profitable growth in a mobile business. Aug 20, 2009
Assunta Krehl

Agriculture proving its worth in today's economy - Guelph Mercury - 0 views

  • The recent Agri-Innovation Forum, hosted in Toronto by a few Guelph-based organizations like MaRS Landing and Ontario Agri-Food Technologies who are dedicated to building linkages between agriculture and other sectors such as health, highlighted some of these developments.
  •  
    Argiculture industry has escaped the bad economy thus far and the many of the nutraceutcals and other innovative food products are doing well. Mention of MaRS Landing and Ontaro Agri-Fod Technologies hosted an Agri-Innovation Forum which highlight developments of the linkages built betweem agriculture and sectors in health.
  •  
    Argiculture industry has escaped the bad economy thus far and the many of the nutraceutcals and other innovative food products are doing well. Mention of MaRS Landing and Ontaro Agri-Fod Technologies hosted an Agri-Innovation Forum which highlight developments of the linkages built betweem agriculture and sectors in health. Feb 26, 2009
Cathy Bogaart

Social innovation: a simple model - Francois Couillard Blog, Feb 18, 2011 - 0 views

  •  
    Francois blogs about the continuum of social innovation. He credits MaRS as his inspiration. Find out about the different types of socially innovative organizations and enterprises and how they differ.
Cathy Bogaart

Public Inc - 0 views

  • PUBLIC is a for-profit, social-purpose business focused exclusively on advancing the public good. We are an innovation company, generating positive social impact through the creation of scalable programs, products and campaigns that: raise money for charitable purposes increase civic and community engagement advance social causes and issues create new social norms We bring an integrated, impact- driven approach to mobilizing and advancing the public good by aligning brand awareness, policy influence and fundraising. For us, “advancing the public good” is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
  • generating positive social impact through the creation of scalable programs, products and campaigns
  • advancing the public good” is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
  •  
    An interesting Toronto-based social-purpose business. PUBLIC is a for-profit, social-purpose business focused exclusively on advancing the public good. We are an innovation company, generating positive social impact through the creation of scalable programs, products and campaigns that: * raise money for charitable purposes * increase civic and community engagement * advance social causes and issues * create new social norms We bring an integrated, impact- driven approach to mobilizing and advancing the public good by aligning brand awareness, policy influence and fundraising. For us, "advancing the public good" is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
Cathy Bogaart

Welcome to EUC2C.COM - 0 views

  •  
    This is the kind of environment that Ontario is trying to build: The EuC2C partnership is an inter-sectoral group of organisations committed to making European businesses more innovative and competitive in the long term. The knowledge, skills and networks of the partnership complement each other, containing as it does a communications focussed SME, the world's most specialised firm in helping develop cluster-based programmes, a Europe-wide network of business innovation centres, a non profit national body for SME development, an independent SME training consultancy specialising in multimedia training and a specialist marketing communication company.
Cathy Bogaart

GreenHeroes - Blog - MaRS - 0 views

  •  
    GreenHeroes, a website and TV show, tells the story of people who are "venturing forth" to change the planet. In their blog, they talk about MaRS as a place where science, business and innovation collide in a riot with academia, government, community leaders, private and not-for-profit sectors. We're listed here as a resource for social innovators, in good company with other organizations who want to help entrepreneurs with a social mission.
Sarah Hickman

Making Innovation Work: How to Manage It, Measure It, and Profit from It: Amazon.ca: To... - 0 views

  •  
    This book challenges the prevalent misconceptions about innovation, and lays out the tools and processes necessary for an organization to harness and execute innovation.
1 - 20 of 68 Next › Last »
Showing 20 items per page